Analytical Data
-
Gene name
GRM1
- Application
-
Alternative Names
GPRC1A; MGLUR1
-
Species
Human
-
Source
Baculovirus
-
Tag
His;Flag
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q13255-1
-
Expression Region
I581-V860
-
Protein Length
Partial
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
GRM1, or Glutamate Receptor Metabotropic 1, is a member of the metabotropic glutamate receptor family, which plays a crucial role in modulating synaptic transmission and plasticity in the central nervous system. The study of GRM1 has garnered significant attention in recent years due to its involvement in various neurological disorders, including schizophrenia, neurodegeneration, and mood disorders. Researchers have been particularly interested in GRM1 recombinant proteins to elucidate its functional mechanisms and potential as a therapeutic target. The development of GRM1 recombinant proteins allows for detailed investigations into receptor signaling pathways, ligand-binding characteristics, and interaction with other cellular components. Additionally, these proteins can be utilized in high-throughput screening for potential pharmacological agents that could modulate GRM1 activity, offering insights into novel treatment strategies for associated disorders. Understanding the structure and dynamics of GRM1 through these recombinant proteins could pave the way for advancements in drug discovery, highlighting its significance in neuroscience research.
